Abstract | OBJECTIVE: Over 50% of cancer patients who are treated with epidermal growth factor receptor (EGFR) inhibitors develop a papulopustular rash that involves the face, neck, and upper torso. However, because relatively few previous reports have focused on the full ramifications of this drug-induced side effect, this qualitative study was undertaken. METHODS: Fifteen patients who had either an active or previous rash from these agents participated in scripted interviews. All interviews were transcribed and examined by means of a qualitative methodologic approach. RESULTS: Four major themes emerged: (1) actual physical discomfort was associated with the rash; (2) patients were concerned about their appearance; (3) despite initial denial, patients did suffer social isolation; and (4) high medical morbidity was associated with the rash. Patients voiced concerns such as: (1) 'Especially when I try to sleep, I can feel the itch and burn all over…'; (2) 'My face looks so bad that if I go to see my friends and they say, 'What happened to you.' I am self conscious about that'; (3) 'I just told them they would be better off just calling me, don't come visit…'; and (4) 'I went to the hospital for my face…they made a bandage to put all over [my] face…. [I] just had a little nose hole, a mouth hole and holes for…eyes.'. CONCLUSION:
Rash from EGFR inhibitors can have a major negative impact upon cancer patients.
|
Authors | Shawnta Coleman, Irina Kovtun, Phuong L Nguyen, Mark Pittelkow, Aminah Jatoi |
Journal | Psycho-oncology
(Psychooncology)
Vol. 20
Issue 11
Pg. 1246-9
(Nov 2011)
ISSN: 1099-1611 [Electronic] England |
PMID | 20865737
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 John Wiley & Sons, Ltd. |
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- ErbB Receptors
(antagonists & inhibitors)
- Exanthema
(chemically induced, psychology)
- Female
- Humans
- Interviews as Topic
- Male
- Middle Aged
- Neoplasms
(drug therapy, psychology)
|